» Articles » PMID: 27059652

Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry

Overview
Publisher Wiley
Specialty Rheumatology
Date 2016 Apr 10
PMID 27059652
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Antinuclear antibodies (ANAs) are diagnostic in several autoimmune disorders, yet the failure to achieve B cell tolerance in these diseases is still poorly understood. Although secreted ANAs detected by an indirect immunofluorescence assay are the gold standard for autoreactivity, there has been no convenient assay with which to measure the frequency of circulating B cells that recognize nuclear antigens (ANA+ B cells) in patients. The aim of this study was to generate an assay to easily identify these B cells and to examine its utility in a study of autoreactive B cells in systemic lupus erythematosus (SLE).

Methods: We developed and validated a novel flow cytometry-based assay that identifies ANA+ B cells using biotinylated nuclear extracts, and utilized it to examine B cell tolerance checkpoints in peripheral blood mononuclear cells obtained from SLE patients and healthy controls.

Results: We observed progressive selection against ANA+ B cells as they matured from transitional to naive to CD27+IgD- and CD27+IgD+ memory cells in both healthy subjects and SLE patients; however, ANA+ naive B cells in SLE patients were not anergized to the same extent as in healthy individuals. We also showed that anergy induction is restored in SLE patients treated with belimumab, an inhibitor of BAFF.

Conclusion: This assay will enable studies of large populations to identify potential genetic or environmental factors affecting B cell tolerance checkpoints in healthy subjects and patients with autoimmune disease and permit monitoring of the B cell response to therapeutic interventions.

Citing Articles

Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome.

Moran Alvarez P, Bracaglia C, Nicolai R, Giovannelli L, Caiello I, Boni A Lupus. 2024; 33(14):1594-1604.

PMID: 39494571 PMC: 11613521. DOI: 10.1177/09612033241298729.


Hyperactivation and altered selection of B cells in patients with paediatric Sjogren's syndrome.

Boni A, Nicolai R, Caiello I, Marinaro F, Farina L, Pires Marafon D RMD Open. 2024; 10(1).

PMID: 38453214 PMC: 10921545. DOI: 10.1136/rmdopen-2023-003800.


IgDIgM B Cells in Common Variable Immunodeficiency.

Kasahara T, Gupta S Pathogens. 2024; 13(2).

PMID: 38392874 PMC: 10891963. DOI: 10.3390/pathogens13020136.


Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help.

Fiske B, Getahun A J Immunol. 2024; 212(7):1150-1160.

PMID: 38353615 PMC: 10948302. DOI: 10.4049/jimmunol.2300108.


Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer.

Vojdani A, Koksoy S, Vojdani E, Engelman M, Benzvi C, Lerner A Microorganisms. 2024; 12(1).

PMID: 38276215 PMC: 10818828. DOI: 10.3390/microorganisms12010230.


References
1.
Quach T, Manjarrez-Orduno N, Adlowitz D, Silver L, Yang H, Wei C . Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol. 2011; 186(8):4640-8. PMC: 3095097. DOI: 10.4049/jimmunol.1001946. View

2.
Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig M, Wardemann H . A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med. 2006; 203(2):393-400. PMC: 2118214. DOI: 10.1084/jem.20052033. View

3.
Bagnara D, Squillario M, Kipling D, Mora T, Walczak A, Da Silva L . A Reassessment of IgM Memory Subsets in Humans. J Immunol. 2015; 195(8):3716-24. PMC: 4594759. DOI: 10.4049/jimmunol.1500753. View

4.
Jacobi A, Zhang J, Mackay M, Aranow C, Diamond B . Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One. 2009; 4(6):e5776. PMC: 2685013. DOI: 10.1371/journal.pone.0005776. View

5.
Yurasov S, Hammersen J, Tiller T, Tsuiji M, Wardemann H . B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann N Y Acad Sci. 2006; 1062:165-74. DOI: 10.1196/annals.1358.019. View